Daan Gene Co., Ltd. (SHE:002030)

China flag China · Delayed Price · Currency is CNY
5.79
+0.02 (0.35%)
Apr 29, 2026, 3:04 PM CST
7.22%
Market Cap 8.13B
Revenue (ttm) 737.96M
Net Income (ttm) -895.46M
Shares Out 1.40B
EPS (ttm) -0.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 9,162,413
Average Volume 11,305,647
Open 5.76
Previous Close 5.77
Day's Range 5.72 - 5.81
52-Week Range 5.35 - 8.20
Beta 0.36
RSI 40.61
Earnings Date Apr 3, 2026

About Daan Gene

Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers reagents for hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, coronavirus disease (COVID-19), pharmacogenomics, viral transport medium, human papillomavirus, human immunodeficiency virus, respiratory infections, publi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1988
Employees 1,730
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.